Combination of Everolimus and 177Lu-DOTATATE in the Treatment of Grades 2 and 3 Refractory Meningioma: a Phase IIb Clinical Trial

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

France

CHRU of Nancy, Vandœuvre-lès-Nancy, Grand Est

Nancy Hospital, Vandœuvre-lès-Nancy